The Global Digital Pathology market is projected to reach USD 1,371 million by 2026 from USD 736 million in 2021, at a CAGR of 13.2% during the forecast period. The growth in the digital pathology market is mainly driven by factors such as the increasing adoption of digital pathology to enhance lab efficiency, rising incidence of cancer, and growing applications of digital pathology in drug development and companion diagnostics.
Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics (Japan) were the top players in the Digital Pathology market during the forecast period. Other major players in the market include Sectra AB (Sweden), F. Hoffmann-La Roche Ltd. (Switzerland), Visiopharm A/S (Denmark), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Corista (US), Indica Labs (US), OptraSCAN (India), Glencoe Software (US), Inspirata (US), Mikroscan Technologies (US), and Kanteron Systems (Spain).
To know about the assumptions considered for the study download the pdf brochure
Leica Biosystems (US): In 2020, Leica Biosystems was the largest player in the digital pathology market. The large share of this company can be attributed to its strong suite of scanners and software. Moreover, the company has a strong geographic presence across the globe. It focuses on product launches to create a strong foothold in the market. In 2019, Leica Biosystems launched the Aperio GT 450, a next-generation digital pathology scanner. Similarly, in 2018, the company received approval for its scanner, Aperio LV1 IVD, to be sold in Europe, Canada, Australia, and New Zealand.
Koninklijke Philips N.V. (Netherlands): In 2020, Philips was the second-largest player in the digital pathology market. The company offers scanners, software, communication systems, and storage systems for digital pathology. The company focuses on intelligent, integrated solutions (AI-enabled suites of systems, smart devices, software, and services) that help healthcare providers meet clinical, operational, and financial goals. Philips supports clinicians in precision diagnosis by integrating multiple sources of information across imaging, pathology, and genomics to create a comprehensive single-patient view.
Philips strategically focuses on collaborating and partnering with other market players to launch technologically advanced products and expand globally. In line with this, the company collaborated with Paige (US) to deliver AI-based clinical pathology diagnostic solutions in 2019. This collaboration is expected to deliver clinical-grade AI applications to pathology laboratories. Similarly, in 2017, the company partnered with PathAI (US) to jointly develop solutions to improve the precision and accuracy of the routine diagnosis of cancer and other diseases. This partnership enabled Philips to apply AI to massive pathology data sets for informed diagnostic and treatment decisions.
Hamamatsu Photonics (Japan): In 2020, Hamamatsu Photonics was the third-largest player in the digital pathology market. The company is a leading provider of photoelectron conversion technologies. It offers 90 types of image sensors, light sources, components, and systems with capabilities that span the spectrum from X-ray to infrared. In the year 2020, Hamamatsu invested 8.7% of its total revenue in R&D activities. It geographically operates across the Americas, Europe, and Asia. The company has 17 subsidiaries operating across the US, Japan, China, Germany, France, Sweden, Italy, and the UK.
Digital Pathology Market by Product( ArtificiaI Intelligence, Scanner, Software, Storage), Type(Human, Veterinary), Application( Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User( Pharma, Academia, Hospitals ) - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE